Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule of Reconciliation of Adjusted EBITDA (Details)

v3.25.1
Schedule of Reconciliation of Adjusted EBITDA (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]                        
Income from continuing operations (GAAP Basis)                     $ (8,100)  
Depreciation and amortization     $ 52     $ 356 $ 119 $ 714 $ 205 $ 954    
Tax expense $ 4 $ 4 4 $ 4 $ 4 4 8 8 12 12 4 $ 17
Interest accretion expense $ 4 $ 12 $ 19 $ 26 $ 31 $ 35 $ 30 $ 66 $ 34 $ 92    
Change in fair value of contingent consideration                     7
Reportable Segment [Member]                        
Segment Reporting Information [Line Items]                        
Income from continuing operations (GAAP Basis)                     6,946 2,264
Depreciation and amortization                     300 1,026
Stock-based compensation                     291 630
Tax expense                     4 17
Interest accretion expense                     34 112
Financing interest and related costs                     625 896
Interest income                     (48) (53)
Change in fair value of note payable                     547 678
Change in fair value of contingent consideration                     7
Adjusted EBITDA                     $ 8,699 $ 5,577